Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Hematologic Oncology Update
00:00
The Potential of Checkpoint Inhibitors in AML and MDS
The speakers discuss the current limitations of checkpoint inhibitors in treating AML and MDS and highlight the potential of targeting the innate immune system for better outcomes. Ongoing studies and clinical trials in this area are also discussed.
Transcript
Play full episode
